Pharmacist Interventions and Medication Adherence of H. Pylori-Infected Patients: A Review of Randomized Controlled Studies http://www.doi.org/10.26538/tjnpr/v7i4.2
Article Sidebar
Main Article Content
Abstract
The Helicobacter pylori (H. Pylori) eradication regimen challenges patient medication adherence. Pharmacists play an essential role in supporting medication adherence to achieve treatment efficacy. This review aimed to evaluate the effect of pharmaceutical interventions on medication adherence in patients with H. Pylori infection taking eradication regimens. The literature was reviewed using Scopus, ScienceDirect, PubMed, and Google Scholar. Keywords included adherence, pharmacist intervention, H. Pylori, and eradication regimen. We collected original articles published in English from January 2002 to December 2022 describing pharmacist interventions to improve medication adherence in adult patients with H. Pylori infection We assessed adherence rates before and after the intervention. Two independent researchers extracted relevant data for the inclusion criteria and assessed the methodological quality of studies using the Joanna Briggs Institute Critical Appraisal Checklist Tools. A total of 413 articles were retrieved, of which six were eligible for review. The most common pharmacist intervention strategy was a combination of patient education with oral and written information provided. The findings suggest that pharmacist interventions support the improvement of medication adherence and highlight the role of pharmacist interventions in enhancing overall health outcomes. Further studies must assess the long-term effects and clinical outcomes of pharmacist interventions.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Khoder G, Muhammad JS, Mahmoud I, Soliman SSM, Burucoa C. Prevalence of Helicobacter
pylori and its associated factors among healthy asymptomatic residents in the United Arab
Emirates. Pathogens. 2019;8(2):44.
van Mil JWF. Pharmaceutical Care Made Easy: John Sexton, Gareth Nickless and Chris Green,
Pharmaceutical Press, London, 2006,£ 19.95, ISBN 0-85369-650-0. Published online 2007.
Svedlund J, Sjödin I, Dotevall G, et al. Medication adherence pattern and factors affecting
adherence in Helicobacter Pylori eradication therapy. Pajares JM, Peña AS, Malfertheiner P, eds.
World J Gastroenterol. 2014;20(2):6961-6965. doi:10.1001/archinte.159.19.2312
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and
persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
Jama. 2006;296(21):2563-2571.
Stevens VJ, Shneidman RJ, Johnson RE, Boles M, Steele PE, Lee NL. Helicobacter pylori
eradication in dyspeptic primary care patients: a randomized controlled trial of a pharmacy
intervention. West J Med. 2002;176(2):92.
Gisbert JP, Calvet X. the effectiveness of standard triple therapy for Helicobacter pylori has not
changed over the last decade, but it is not good enough. Aliment Pharmacol Ther. 2011;34(11‐
:1255-1268.
Tarif S Bin, Gamaz A, Khasawneh H, Al Shebli H, Al Sharari D. Prevalence of Helicobacter Pylori
in symptomatic patients post triple therapy eradication in Jordan. Int J Med Investig.
;4(2):249-251.
Fürthauer J, Flamm M, Sönnichsen A. Patient and physician related factors of adherence to
evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a
cross sectional study. BMC Fam Pract. 2013;14(1):1-8.
Aleena Francis, Arathi S. Nair, Limi Joseph Gomez BAR, Soumya R. V PGR. Assessment of
medication adherence in Helicobacter pylori positive patients on standard triple therapy: a
prospective study. Int J Basic Clin Pharmacol. 9(7):1100-1105.
doi:http://dx.doi.org/10.18203/2319-2003.ijbcp20202949
Shoiab AA, Aziz NA, Hassan Y, Alefan Q. The Positive Impact of Patient’s Knowledge on
Medication Adherence Among Helicobacter pylori Infected Outpatients. Adv Sci Lett.
;24(9):6961-6965.
Al‐Eidan FA, McElnay JC, Scott MG, McConnell JB. Management of Helicobacter pylori
eradication–the influence of structured counselling and follow‐up. Br J Clin Pharmacol.
;53(2):163-171.
Chen Y, Yuan H, Ye H, et al. Application of a semi‐automatic, intensive follow‐up for improving
efficacy and adherence of Helicobacter pylori eradication therapy: A randomized controlled trial.
Microbiologyopen. 2021;10(1):e1172.
Luo M, Hao Y, Tang M, et al. Application of a social media platform as a patient reminder in the
treatment of Helicobacter pylori. Helicobacter. 2020;25(2):e12682.
Coutsouvelis J, Siderov J, Tey AY, et al. The impact of pharmacist‐led strategies implemented to
reduce errors related to cancer therapies: a systematic review. J Pharm Pract Res. 2020;50(6):466-
Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure
treatment adherence. Med Pharm reports. 2019;92(2):117-122.
McCue DA, Lohr LK, Pick AM. Improving adherence to oral cancer therapy in clinical practice.
Pharmacother J Hum Pharmacol Drug Ther. 2014;34(5):481-494.
Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015.
Gascon JJ, Sánchez-Ortuño M, Llor B, Skidmore D, Saturno PJ. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21(2):125-130.
Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to
interviews, focus groups, and questionnaires. Immunol Allergy Clin. 2005;25(1):107-130.
Seo M-A, Min S-K. Development of a structural model explaining medication compliance of
persons with schizophrenia. Yonsei Med J. 2005;46(3):331-340.
Hamburg BA, Inoff GE. Relationships between behavioral factors and diabetic control in children
and adolescents: a camp study. Psychosom Med. 1982;44(4):321-339.
Jokisalo E, Kumpusalo E, Enlund H, Takala J. Patients’ perceived problems with hypertension and
attitudes towards medical treatment. J Hum Hypertens. 2001;15(11):755-761.
Osipenko MF, Livzan MA, Bikbulatova EA. Patient compliance as one of the factors determining
the efficiency of eradication therapy. Ter Arkh. 2014;86(2):27-31.
Gossey JT, Whitney SN, Crouch MA, Jibaja-Weiss ML, Zhang H, Volk RJ. Promoting knowledge
of statins in patients with low health literacy using an audio booklet. Patient Prefer Adherence.
Published online 2011:397-403.
Awwad O, Akour A, Al-Muhaissen S, Morisky D. The influence of patients’ knowledge on
adherence to their chronic medications: a cross-sectional study in Jordan. Int J Clin Pharm.
;37(3):504-510.
van Mil JWF. John Sexton, Gareth Nickless and Chris Green, Pharmaceutical Care Made Easy.
Published online 2007.
Chua SS, Kok LC, Yusof FAM, et al. Pharmaceutical care issues identified by pharmacists in
patients with diabetes, hypertension or hyperlipidaemia in primary care settings. BMC Health Serv
Res. 2012;12(1):388.